Moujtaba Y. Kasmani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Moujtaba Y. Kasmani has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Weiguo Cui
Northwestern University Feinberg School of Medicine
20 shared publications Yao Chen
Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, USA
13 shared publicationsRobert Burns
Blood Research Institute, Versiti Wisconsin, Milwaukee, USA
12 shared publications- Chien-Wei Lin
Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, USA
10 shared publications - Paytsar Topchyan
Blood Research Institute, Versiti Wisconsin, Milwaukee, WI 53226, USA
9 shared publications Achia Khatun
Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, USA
7 shared publications
Latest Publications
- 11 November 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223  (12)
Early fate bias and TCR sequence shape CD8+ T cell differentiation and expansion
When a naive CD8+ T cell encounters an antigen, it proliferates into descendants with identical T cell receptors (TCRs), termed clones. Whether their differentiation toward effector or memory fates is stochastic or TCR-dependent has remained unclear, largely because the vast diversity of TCRs makes individual clones difficult to trace over time. Using single-cell RNA and TCR sequencing in acute LCMV Armstrong infection, we found that clonal distributions in blood reflect those in lymphoid organs, enabling nonlethal longitudinal tracking of clonal evolution. Tracing hundreds of clones, we found that memory clonal distribution is surprisingly uncoupled from early dominance; instead, early central memory precursor frequency predicts memory dominance. Leveraging convergent recombination, we identified clones with identical CDR3 amino acid sequences in mice and found that these natural biological replicates were more likely than chance to adopt similar fates, although substantial clone-to-clone variation remained. Applying the TCR distance algorithm, we further identified dominant motifs associated with enhanced expansion and effector-biased transcriptional programs, extending the TCR’s role in shaping clonal differentiation.
- 11 November 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223  (12)
Early fate bias and TCR sequence shape CD8+ T cell differentiation and expansion
When a naive CD8+ T cell encounters an antigen, it proliferates into descendants with identical T cell receptors (TCRs), termed clones. Whether their differentiation toward effector or memory fates is stochastic or TCR-dependent has remained unclear, largely because the vast diversity of TCRs makes individual clones difficult to trace over time. Using single-cell RNA and TCR sequencing in acute LCMV Armstrong infection, we found that clonal distributions in blood reflect those in lymphoid organs, enabling nonlethal longitudinal tracking of clonal evolution. Tracing hundreds of clones, we found that memory clonal distribution is surprisingly uncoupled from early dominance; instead, early central memory precursor frequency predicts memory dominance. Leveraging convergent recombination, we identified clones with identical CDR3 amino acid sequences in mice and found that these natural biological replicates were more likely than chance to adopt similar fates, although substantial clone-to-clone variation remained. Applying the TCR distance algorithm, we further identified dominant motifs associated with enhanced expansion and effector-biased transcriptional programs, extending the TCR’s role in shaping clonal differentiation.
- Open Access
- 18 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14  (1) , 1-19
A spatial sequencing atlas of age-induced changes in the lung during influenza infection
Influenza virus infection causes increased morbidity and mortality in the elderly. Aging impairs the immune response to influenza, both intrinsically and because of altered interactions with endothelial and pulmonary epithelial cells. To characterize these changes, we performed single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and bulk RNA sequencing (bulk RNA-seq) on lung tissue from young and aged female mice at days 0, 3, and 9 post-influenza infection. Our analyses identified dozens of key genes differentially expressed in kinetic, age-dependent, and cell type-specific manners. Aged immune cells exhibited altered inflammatory, memory, and chemotactic profiles. Aged endothelial cells demonstrated characteristics of reduced vascular wound healing and a prothrombotic state. Spatial transcriptomics identified novel profibrotic and antifibrotic markers expressed by epithelial and non-epithelial cells, highlighting the complex networks that promote fibrosis in aged lungs. Bulk RNA-seq generated a timeline of global transcriptional activity, showing increased expression of genes involved in inflammation and coagulation in aged lungs. Our work provides an atlas of high-throughput sequencing methodologies that can be used to investigate age-related changes in the response to influenza virus, identify novel cell-cell interactions for further study, and ultimately uncover potential therapeutic targets to improve health outcomes in the elderly following influenza infection.
- 18 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14  (1) , 1-19
Open AccessA spatial sequencing atlas of age-induced changes in the lung during influenza infection
Influenza virus infection causes increased morbidity and mortality in the elderly. Aging impairs the immune response to influenza, both intrinsically and because of altered interactions with endothelial and pulmonary epithelial cells. To characterize these changes, we performed single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and bulk RNA sequencing (bulk RNA-seq) on lung tissue from young and aged female mice at days 0, 3, and 9 post-influenza infection. Our analyses identified dozens of key genes differentially expressed in kinetic, age-dependent, and cell type-specific manners. Aged immune cells exhibited altered inflammatory, memory, and chemotactic profiles. Aged endothelial cells demonstrated characteristics of reduced vascular wound healing and a prothrombotic state. Spatial transcriptomics identified novel profibrotic and antifibrotic markers expressed by epithelial and non-epithelial cells, highlighting the complex networks that promote fibrosis in aged lungs. Bulk RNA-seq generated a timeline of global transcriptional activity, showing increased expression of genes involved in inflammation and coagulation in aged lungs. Our work provides an atlas of high-throughput sequencing methodologies that can be used to investigate age-related changes in the response to influenza virus, identify novel cell-cell interactions for further study, and ultimately uncover potential therapeutic targets to improve health outcomes in the elderly following influenza infection.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Data from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
There is a strong correlation between myeloid-derived suppressor cells (MDSC) and resistance to immune checkpoint blockade (ICB), but the detailed mechanisms underlying this correlation are largely unknown. Using single-cell RNA sequencing analysis in a bilateral tumor model, we found that immunosuppressive myeloid cells with characteristics of fatty acid oxidative metabolism dominate the immune-cell landscape in ICB-resistant subjects. In addition, we uncovered a previously underappreciated role of a serine/threonine kinase, PIM1, in regulating lipid oxidative metabolism via PPARγ-mediated activities. Enforced PPARγ expression sufficiently rescued metabolic and functional defects of Pim1−/− MDSCs. Consistent with this, pharmacologic inhibition of PIM kinase by AZD1208 treatment significantly disrupted the myeloid cell–mediated immunosuppressive microenvironment and unleashed CD8+ T-cell–mediated antitumor immunity, which enhanced PD-L1 blockade in preclinical cancer models. PIM kinase inhibition also sensitized nonresponders to PD-L1 blockade by selectively targeting suppressive myeloid cells. Overall, we have identified PIM1 as a metabolic modulator in MDSCs that is associated with ICB resistance and can be therapeutically targeted to overcome ICB resistance.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
There is a strong correlation between myeloid-derived suppressor cells (MDSC) and resistance to immune checkpoint blockade (ICB), but the detailed mechanisms underlying this correlation are largely unknown. Using single-cell RNA sequencing analysis in a bilateral tumor model, we found that immunosuppressive myeloid cells with characteristics of fatty acid oxidative metabolism dominate the immune-cell landscape in ICB-resistant subjects. In addition, we uncovered a previously underappreciated role of a serine/threonine kinase, PIM1, in regulating lipid oxidative metabolism via PPARγ-mediated activities. Enforced PPARγ expression sufficiently rescued metabolic and functional defects of Pim1−/− MDSCs. Consistent with this, pharmacologic inhibition of PIM kinase by AZD1208 treatment significantly disrupted the myeloid cell–mediated immunosuppressive microenvironment and unleashed CD8+ T-cell–mediated antitumor immunity, which enhanced PD-L1 blockade in preclinical cancer models. PIM kinase inhibition also sensitized nonresponders to PD-L1 blockade by selectively targeting suppressive myeloid cells. Overall, we have identified PIM1 as a metabolic modulator in MDSCs that is associated with ICB resistance and can be therapeutically targeted to overcome ICB resistance.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figures 1-8 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
Supplemental Figures 1-8 plus Legends
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figures 1-8 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
Supplemental Figures 1-8 plus Legends
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Data from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
There is a strong correlation between myeloid-derived suppressor cells (MDSC) and resistance to immune checkpoint blockade (ICB), but the detailed mechanisms underlying this correlation are largely unknown. Using single-cell RNA sequencing analysis in a bilateral tumor model, we found that immunosuppressive myeloid cells with characteristics of fatty acid oxidative metabolism dominate the immune-cell landscape in ICB-resistant subjects. In addition, we uncovered a previously underappreciated role of a serine/threonine kinase, PIM1, in regulating lipid oxidative metabolism via PPARγ-mediated activities. Enforced PPARγ expression sufficiently rescued metabolic and functional defects of Pim1−/− MDSCs. Consistent with this, pharmacologic inhibition of PIM kinase by AZD1208 treatment significantly disrupted the myeloid cell–mediated immunosuppressive microenvironment and unleashed CD8+ T-cell–mediated antitumor immunity, which enhanced PD-L1 blockade in preclinical cancer models. PIM kinase inhibition also sensitized nonresponders to PD-L1 blockade by selectively targeting suppressive myeloid cells. Overall, we have identified PIM1 as a metabolic modulator in MDSCs that is associated with ICB resistance and can be therapeutically targeted to overcome ICB resistance.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
There is a strong correlation between myeloid-derived suppressor cells (MDSC) and resistance to immune checkpoint blockade (ICB), but the detailed mechanisms underlying this correlation are largely unknown. Using single-cell RNA sequencing analysis in a bilateral tumor model, we found that immunosuppressive myeloid cells with characteristics of fatty acid oxidative metabolism dominate the immune-cell landscape in ICB-resistant subjects. In addition, we uncovered a previously underappreciated role of a serine/threonine kinase, PIM1, in regulating lipid oxidative metabolism via PPARγ-mediated activities. Enforced PPARγ expression sufficiently rescued metabolic and functional defects of Pim1−/− MDSCs. Consistent with this, pharmacologic inhibition of PIM kinase by AZD1208 treatment significantly disrupted the myeloid cell–mediated immunosuppressive microenvironment and unleashed CD8+ T-cell–mediated antitumor immunity, which enhanced PD-L1 blockade in preclinical cancer models. PIM kinase inhibition also sensitized nonresponders to PD-L1 blockade by selectively targeting suppressive myeloid cells. Overall, we have identified PIM1 as a metabolic modulator in MDSCs that is associated with ICB resistance and can be therapeutically targeted to overcome ICB resistance.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figures 1-8 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
Supplemental Figures 1-8 plus Legends
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figures 1-8 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
Supplemental Figures 1-8 plus Legends
- 5 March 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210  (9) , 1281-1291
Lymphocytic Choriomeningitis Virus Clone 13 Infection Results in CD8 T Cell–Mediated Host Mortality in Diacylglycerol Kinase α–Deficient Mice
Diacylglycerol is a potent element of intracellular secondary signaling cascades whose production is enhanced by cell-surface receptor agonism and function is regulated by enzymatic degradation by diacylglycerol kinases (DGKs). In T cells, stringent regulation of the activity of this second messenger maintains an appropriate balance between effector function and anergy. In this article, we demonstrate that DGKα is an indispensable regulator of TCR-mediated activation of CD8 T cells in lymphocytic choriomeningitis virus Clone 13 viral infection. In the absence of DGKα, Clone 13 infection in a murine model results in a pathologic, proinflammatory state and a multicellular immunopathologic host death that is predominantly driven by CD8 effector T cells.
- 5 March 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210  (9) , 1281-1291
Lymphocytic Choriomeningitis Virus Clone 13 Infection Results in CD8 T Cell–Mediated Host Mortality in Diacylglycerol Kinase α–Deficient Mice
Diacylglycerol is a potent element of intracellular secondary signaling cascades whose production is enhanced by cell-surface receptor agonism and function is regulated by enzymatic degradation by diacylglycerol kinases (DGKs). In T cells, stringent regulation of the activity of this second messenger maintains an appropriate balance between effector function and anergy. In this article, we demonstrate that DGKα is an indispensable regulator of TCR-mediated activation of CD8 T cells in lymphocytic choriomeningitis virus Clone 13 viral infection. In the absence of DGKα, Clone 13 infection in a murine model results in a pathologic, proinflammatory state and a multicellular immunopathologic host death that is predominantly driven by CD8 effector T cells.
- Open Access
- 31 October 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220  (1)
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection
Although recent evidence demonstrates heterogeneity among CD8+ T cells during chronic infection, developmental relationships and mechanisms underlying their fate decisions remain incompletely understood. Using single-cell RNA and TCR sequencing, we traced the clonal expansion and differentiation of CD8+ T cells during chronic LCMV infection. We identified immense clonal and phenotypic diversity, including a subset termed intermediate cells. Trajectory analyses and infection models showed intermediate cells arise from progenitor cells before bifurcating into terminal effector and exhausted subsets. Genetic ablation experiments identified that type I IFN drives exhaustion through an IRF7-dependent mechanism, possibly through an IFN-stimulated subset bridging progenitor and exhausted cells. Conversely, Zeb2 was critical for generating effector cells. Intriguingly, some T cell clones exhibited lineage bias. Mechanistically, we identified that TCR avidity correlates with an exhausted fate, whereas SHP-1 selectively restricts low-avidity effector cell accumulation. Thus, our work elucidates novel mechanisms underlying CD8+ T cell fate determination during persistent infection and suggests two potential pathways leading to exhaustion.
- 31 October 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220  (1)
Open AccessClonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection
Although recent evidence demonstrates heterogeneity among CD8+ T cells during chronic infection, developmental relationships and mechanisms underlying their fate decisions remain incompletely understood. Using single-cell RNA and TCR sequencing, we traced the clonal expansion and differentiation of CD8+ T cells during chronic LCMV infection. We identified immense clonal and phenotypic diversity, including a subset termed intermediate cells. Trajectory analyses and infection models showed intermediate cells arise from progenitor cells before bifurcating into terminal effector and exhausted subsets. Genetic ablation experiments identified that type I IFN drives exhaustion through an IRF7-dependent mechanism, possibly through an IFN-stimulated subset bridging progenitor and exhausted cells. Conversely, Zeb2 was critical for generating effector cells. Intriguingly, some T cell clones exhibited lineage bias. Mechanistically, we identified that TCR avidity correlates with an exhausted fate, whereas SHP-1 selectively restricts low-avidity effector cell accumulation. Thus, our work elucidates novel mechanisms underlying CD8+ T cell fate determination during persistent infection and suggests two potential pathways leading to exhaustion.